The increasing recognition of green tea and tea polyphenols as cancer preventives has created a need for a study of their bioavailability. For this purpose, we synthesized [ 3 H] (-)-epigallocatechin gallate ([ 3 H]EGCG) with a specific activity of 48.1 GBq/mmol and directly administered the solution into the stomachs of CD-1 female or male mice. Radioactivity in the digestive tract, various organs, blood, urine and feces was measured with an oxidizer at various times after administration and significant radioactivity was found in the previously reported target organs of EGCG and green tea extract (digestive tract, liver, lung, pancreas, mammary gland and skin), as well as other organs (brain, kidney, uterus and ovary and testes) in both sexes. Incorporation of radioactivity in the cells was confirmed by microautoradiography. Within 24 h, 6.6 (females) and 6.4% (males) of total administered radioactivity was excreted in the urine and 37.7 and 33.1% in feces. HPLC analysis of urine from both sexes revealed that 0.03-0.59% of administered [ 3 H]EGCG, along with at least five metabolites, was excreted. In addition, we found that a second, equal administration to female mice after a 6 h interval enhanced tissue levels of radioactivity in blood, brain, liver, pancreas, bladder and bone 4-6 times above those after a single administration. These results suggest that frequent consumption of green tea enables the body to maintain a high level of tea polyphenols and this paper is the first pharmacological evidence of a wide distribution of [ 3 H]EGCG in mouse organs, indicating a similar wide range of target organs for cancer prevention in humans.
Introduction
In 1987, our results showing inhibition of tumor promotion by (-)-epigallocatechin gallate (EGCG), a tea polyphenol with a molecular weight of 458, opened up the study of the cancer preventive properties of EGCG and other tea polyphenols (1, 2) . The inhibitory effects of EGCG and green tea extract on carcinogenesis in various organs in rodents have now been demonstrated over the past decade. Specifically, EGCG and green tea extract in drinking water effectively inhibit carcinogenesis in the esophagus, glandular stomach, duodenum, colon, liver, pancreas, lung, breast and skin (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) and EGCG in drinking water also inhibits metastasis of B16 melanoma cells into the lungs (14) . At present, both EGCG and green tea extract are acknowledged practical cancer preventive agents (15) , but to fully appreciate their significance, it was necessary to study how EGCG and green tea extract in drinking water are incorporated into various organs, along with their metabolism.
Tea (Camellia sinensis) is widely consumed throughout the world as black tea, oolong tea and green tea. Approximately 26% of the solid weight of green tea extract is tea polyphenols and EGCG constitutes 11% of these (16) . The composition and content of tea polyphenols undergo changes during the fermentation process: The content of EGCG in black tea, the most fermented tea, is less than in green tea, whereas the content of theaflavins is higher in black tea. All this was known and, moreover, a prospective cohort study in Saitama Prefecture revealed the cancer preventive effects of drinking green tea in humans (17) . However, the bioavailability and metabolic fate of tea polyphenols have not been fully understood. A few papers had reported on HPLC analysis of tea polyphenols in plasma and urinary samples of humans or rats after ingestion of green tea (18) (19) (20) (21) . These papers demonstrated that tea polyphenols, including EGCG, (-)-epigallocatechin (EGC) and (-)-epicatechin (EC), were incorporated into the blood only a few hours after oral administration and excreted into urine as conjugated forms, e.g. glucuronide and sulfate. However, a more detailed study of their bioavailability, using radiolabeled tea polyphenols, was needed.
Accordingly, we recently obtained [ 3 H]EGCG, labeled with 3 H with a specific activity of 48.1 GBq/mmol, as a tool for a bioavailability study (Figure 1) 3 H were in one of the aromatic rings estimated from the 3 H NMR; it was not possible to specifically identify the sites. The 3 H label in EGCG was quite stable, confirming that it did not exchange with water over a period of 24 h. The specific activity of [ 3 H]EGCG was 48.1 GBq/mmol and the EGCG used for all the experiments was 99.7% pure.
Animals
Female and male CD-1 mice, 7 weeks old, were obtained from Charles River Japan (Kanagawa, Japan). Mice were given no nourishment for~15 h before gastric intubation. Blood. Radioactivity in blood was measured with an oxidizer using filter paper blotted with 50 µl blood.
Various organs. Radioactivity of various organs was measured with an oxidizer using 100-150 mg tissue from each organ. All radioactivity in the organs was expressed as d.p.m./100 mg tissue and total radioactivity incorporated was obtained from radioactivity per 100 mg tissue multiplied by the weight of the organ. More than 98% of total radioactivity was recovered by the oxidizer. Data represent the means of two mice of each sex.
Cumulative excretion of radioactivity in feces and urine
Feces and urine of female and male mice were collected for 0-3, 0-6 or 0-24 h in a metabolic cage after a single administration of [ 3 H]EGCG. Radioactivity of all feces samples collected in each period was measured with an oxidizer. The volume of urine samples was measured and 50 µl of each urine sample dissolved in 10 ml Aquazol was counted in a scintillation counter.
HPLC analysis of radioactive metabolites in urine
The urine of female and male mice was mixed with an equal volume of 0.1 N HCl before analysis by HPLC. The urine mixture plus 10 µg EGCG was applied to a C18 Bond Elut cartridge (Varian, Harbor, CA) and eluted with water followed by methanol. More than 95% of EGCG was recovered in the methanol eluent from C18 Bond Elut. The radioactivity of urine samples in the methanol eluent was 57.3-77.7% of applied radioactivity. The methanol eluent from C18 Bond Elut was analyzed by HPLC as follows: column, YMC Pack ODS-A (YMC, Kyoto, Japan); solvent, water/methanol/acetic acid (80:16:4); flow rate, 1 ml/min; detection, UV 280 nm. Fractions of 1 ml were collected and radioactivity was measured in a scintillation counter.
Tissue distribution of radioactivity in female mice after a duplicate administration of [ 3 H]EGCG
Six hours after the first administration of [ 3 H]EGCG with 3.7 MBq/200 µl 0.05% EGCG solution, a second administration of [ 3 H]EGCG with the same radioactivity as the first was given in the female mouse stomach. Six hours after a second administration, the radioactivity of blood, digestive tract, various organs, urine and feces was measured as mentioned above. Total radioactivity after two administrations was compared with that after a single administration.
Microautoradiography of mouse tissue
Twenty-four hours after administration of (23) . After being kept for 3 weeks in a darkroom at 4°C, slides were developed with D-19 developer (Eastman Kodak, Rochester, NY). The tissues were stained with DiffQuick (International Reagents, Kobe, Japan). Silver grains were observed by microscopic examination. Tissues of nontreated female mice were used as controls.
Results

Distribution of radioactivity in mice after a single administration of [ 3 H]EGCG
Digestive tract. Average percent of total administered radioactivity in the digestive tract, including dietary content, of female mice was 30.7, 40.6 and 3.9% for the stomach, small intestine and colon, respectively, 1 h after administration (Table  I) . The results with male mice were almost identical to those for female mice (Table I) . Twenty-four hours after administration, radioactivity in the digestive tract (stomach ϩ small intestine ϩ colon) had decreased, but 14.5% of total administered radioactivity for female mice and 18.2% for male mice remained (Table I) . Specifically, after 24 h radioactivity per 100 mg tissue in female mice was measured at 328.0ϫ10 3 (Table IIa) . In male mice, radioactivity in blood was 22.0ϫ10 3 , 189.0ϫ10 3 and 269.0ϫ10 3 d.p.m./ml at 1, 6 and 24 h after respectively (Table  IIb) , i.e.~2% of total administered radioactivity had been incorporated into total blood in female and male mice 24 h after intubation. This radioactivity was not separated into free EGCG, its metabolites or the protein-bound forms of EGCG; it was calculated as 1.2 µg/ml EGCG under the assumption that all radioactivity was [ 3 H]EGCG. Various organs. Radioactivity was found in various organs in female and male, such as the brain, lung, heart, liver, kidney, spleen, pancreas, uterus and ovary, mammary gland, testes, bladder, bone and skin. The radioactivity per 100 mg tissue of these organs at different intervals after administration is shown in Table II . Although there are individual variations, it is clear that radioactivity was found in the organs in which inhibition of carcinogenesis by EGCG or green tea extract in drinking water has previously been demonstrated, as well as in other organs. Radioactivity in almost all organs gradually increased up to 24 h and was found to be~1.7-22.5ϫ10 3 d.p.m./100 mg tissue in female brain and 1.3-17.3ϫ10 3 d.p.m./ 100 mg tissue in male brain. Radioactivity was equally distributed among almost all organs in mouse of both sexes 24 h after administration. Total radioactivity incorporated was 0.89% for liver, 0.32% for brain, 0.28% for kidney and 0.16% for lung in female and 0.67, 0.33, 0.43 and 0.16% for the same organs respectively in male. The percentages are those of total administered radioactivity and differences obviously reflect the sizes of the organs. Cumulative excretion of radioactivity in feces and urine Radioactivity excreted in feces and urine of both sexes for different intervals (0-3, 0-6 and 0-24 h) was determined. In female, 0.9, 23.4 and 37.7% of total administered radioactivity was excreted in feces and 1.7, 1.4 and 6.6% in urine within 3, 6 and 24 h respectively (Figure 2A ). In male, 2.0, 20.9 and 33.0% was excreted in feces and 1.9, 4.0 and 6.4% in urine Figure 3 shows the HPLC profile of a methanol eluent of a C18 Bond Elut cartridge column of urine collected at 0-6 h from a female mouse. One of the radioactive peaks coincided with a peak of unlabeled EGCG eluted at 10 min. HPLC profiles of urine samples of male mice were similar to those of female (data not shown). The results allowed us to calculate that original [ 3 H]EGCG excreted in urine collected for 6 h was~6% of total radioactivity in urine of female mouse and 5% in male. Urine samples collected after 3 and 24 h from females contained~2 and 9% [ 3 H]EGCG; the figures were~3 and 9% in male (data not shown). These results indicate that 0.03-0.59% of total administered [ 3 H]EGCG was excreted in the urine of both sexes. The other five peaks in the HPLC profile may represent EGCG metabolites, based on available literature (24) .
Tissue distribution of radioactivity in female mice after a duplicate administration of [ 3 H]EGCG
Based on the fact that the Japanese drink green tea throughout the day, we performed an experiment to determine whether a duplicate administration of [ 3 H]EGCG would enhance radioactivity in blood and organs. As Table III shows, a second, equal administration of [ 3 H]EGCG increased radioactivity in blood by as much as 5.9 times over a single administration at 6 h after the second administration. Increases Ͼ4-fold were found in the brain, lung, liver, pancreas, bladder and bone. However, the radioactivity of the digestive tract, including dietary content, showed a less dramatic increase, 1.3-to 2.0-fold. Interestingly, radioactivity of urine increased 6.1-fold after the second dose. In addition, increased incorporation was also observed at 24 h after the second administration, i.e. radioactivity in blood, brain, lung, liver, pancreas and bone had increased Ͼ3-fold compared with that at 24 h after a single administration (data not shown). These results indicate that drinking green tea many times a day increases the level of tea polyphenols in blood and various organs, suggesting that a high concentration of tea polyphenols can be maintained with the usual Japanese lifestyle. administered [ 3 H]EGCG were subjected to microautoradiography 24 h later. Silver grains indicating radioactive compounds were found in cells of the tested organs, such as colon mucosa and lung, but not in non-treated organs (Figure 4) . It is important to note that silver grains were found in some cells of the tissues, but not in all cells homogeneously, suggesting the presence of unique specific mechanisms of incorporation of EGCG. 
Microautoradiography of mouse tissue To confirm whether administered [ 3 H]EGCG is incorporated into cells of various organs, tissue sections of female mice
Discussion
This paper provides significant evidence that EGCG, the main constituent of green tea, is easily absorbed from the digestive tract and widely distributed into various organs of mouse. Although 3 H label is thought to be easily exchanged with water, the actual exchange rate of [ 3 H]EGCG with water was (24, 25) , we think that wide distribution is an important and specific feature of EGCG, a tea polyphenol. HPLC analyses with a methanol fraction of urine indicated that tea polyphenols have various metabolites, based on evidence that intestinal microorganisms metabolize flavonoids through ring fission, hydrolysis, methylation, oxidation and conjugation with glucuronide and sulfate (24, 26) . It has been reported that one conjugate form of EGCG, EGCG 4Ј-monosulfate, is metabolized by arylsulfotransferase of human intestinal bacteria (27) . Sulfate forms and glucuronide forms of catechins (EGCG, EGC and EC) were also found in plasma and urine after oral administration of green tea extract to healthy volunteers (18) . Since the conjugated forms of [ 3 H]EGCG might be contained in the water fraction of urine, further analysis of metabolites is needed. Microautoradiography indicated that radioactivity was incorporated into cells of organs, but that this incorporation was not equal in all cells. Therefore, we think that some cells may readily incorporate EGCG by specific mechanisms. When [ 3 H]EGCG was incubated with the human lung cancer cell line PC-9, radioactivity was incorporated into cytosol and nuclei in vitro (28) . Thus, radioactivity may also be incorporated into the nuclei of organs. Recently, we discovered that incorporation of [ 3 H]EGCG into PC-9 cells is stimulated by EC, suggesting that whole green tea is more effective than pure EGCG (M.Suganuma et al., manuscript in preparation). Whether EGCG in green tea distributes more effectively than EGCG alone should be examined.
Imai et al., in their prospective cohort study of 8552 individuals in Saitama Prefecture, Japan, found delayed cancer onset among patients who drink Ͼ10 cups of green tea per day, compared with that of those consuming Ͻ3 cups per day. Specifically, cancer onset of patients was delayed by 3.0 years (from 65.3 Ϯ 1.5 to 68.3 Ϯ 1.2) among males and 8.7 years (65.7 Ϯ 1.7 to 74.4 Ϯ 2.5) among females (17) . These epidemiological results strongly support evidence that frequent consumption of green tea results in high levels of tea polyphenols in the blood and organs. The study also revealed that relative risk of cancers of the lung, colon and liver decreased from 1.0 to 0.36-0.55 (29) . Interestingly, these organs coincide with those organs having high incorporation of radioactivity in mouse after oral administration of [ 3 H]EGCG. Thus, we conclude that a wide range of target organs for green tea as a cancer preventive in humans correlates well with a wide distribution of [ 3 H]EGCG in organs of mice.
